Pacific Biosciences
PACB
PACB
210 hedge funds and large institutions have $4.42B invested in Pacific Biosciences in 2020 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
6.85% more ownership
Funds ownership: 84.13% → 90.98% (+6.9%)
2% more call options, than puts
Call options by funds: $41M | Put options by funds: $40.2M
Holders
210
Holding in Top 10
6
Calls
$41M
Puts
$40.2M
Top Buyers
| 1 | +$350M | |
| 2 | +$238M | |
| 3 | +$225M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$102M |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
+$56.3M |
Top Sellers
| 1 | -$76.7M | |
| 2 | -$58.9M | |
| 3 | -$57.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$50.9M |
| 5 |
BAMCO Inc
New York
|
-$31.4M |